Cargando…
Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia
Platelet autoantibody-induced platelet clearance represents a major pathomechanism in immune thrombocytopenia (ITP). There is growing evidence for clinical differences between anti-glycoprotein IIb/IIIa and anti-glycoprotein Ib/IX mediated ITP. Glycoprotein V is a well characterized target antigen i...
Autores principales: | Vollenberg, Richard, Jouni, Rabie, Norris, Peter A. A., Burg-Roderfeld, Monika, Cooper, Nina, Rummel, Mathias J., Bein, Gregor, Marini, Irene, Bayat, Behnaz, Burack, Richard, Lazarus, Alan H., Bakchoul, Tamam, Sachs, Ulrich J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545841/ https://www.ncbi.nlm.nih.gov/pubmed/30923095 http://dx.doi.org/10.3324/haematol.2018.211086 |
Ejemplares similares
-
Treatment of drug-induced immune thrombocytopenias
por: Marini, Irene, et al.
Publicado: (2022) -
FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia
por: Norris, Peter A. A., et al.
Publicado: (2020) -
Transfusion of target antigens to preimmunized recipients: a new mechanism in transfusion-related acute lung injury
por: Bayat, Behnaz, et al.
Publicado: (2021) -
Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management
por: Singh, Anurag, et al.
Publicado: (2021) -
Immune-Mediated Platelet Activation in COVID-19 and Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Uzun, Günalp, et al.
Publicado: (2022)